Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.308 SEK | -3.45% | -0.65% | -65.00% |
06-14 | Biosergen AB Approves Board Changes | CI |
06-11 | Biosergen AB Receives the Final Permission Required to Test Lead Candidate BSG005 in Patients with Invasive Fungal Infection | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-65.00% | 4.36M | |
+15.87% | 121B | |
+18.66% | 112B | |
+4.43% | 22.57B | |
-18.25% | 20.82B | |
-14.11% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+1.65% | 13.17B | |
+25.12% | 11.11B |
- Stock Market
- Equities
- BIOSGN Stock
- News Biosergen AB
- Biosergen's Antifungal Drug Candidate Shows Safety in Early-Stage Trial in Australia